| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015016 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 03/21/2006 | US7014867 Tablet comprising cetirizine and pseudoephedrine |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | CA2443214C Vaccine composition comprising human papilloma virus 16 l1 virus-like particle (hpv 16 l1 vlp), human papilloma virus 18 l1 virus-like particle (hpv 18 l1 vlp) and 3-de-o-acylatedmonphosphoryl lipid a (3d-mpl) and alum |
| 03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028164A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | WO2006027685A2 Glycosylceramide adjuvant for saccharide antigens |
| 03/16/2006 | WO2006027579A2 The treatment of inflammatory disorders and pain |
| 03/16/2006 | WO2006027252A1 Sigma receptor ligands |
| 03/16/2006 | WO2005113003A3 Method for augmenting b cell depletion |
| 03/16/2006 | WO2005107711A3 Method and composition for treating rhinitis |
| 03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
| 03/16/2006 | US20060058398 Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof |
| 03/16/2006 | US20060058392 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058279 Topical compositions comprising ascomycins |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057163 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/16/2006 | US20060057160 Vaccine composition |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057064 Useful in SPECT image diagnosis, PET image diagnosis, MRI image diagnosis and the like, for imaging sites of inflammation |
| 03/16/2006 | DE102004043863A1 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum Tablets with place- and time-controlled drug release in the gastrointestinal tract |
| 03/16/2006 | DE102004035337A1 Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität Variants of the group 1 allergens from Poaceae with reduced allergenicity and preserved T cell reactivity |
| 03/16/2006 | CA2579709A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | CA2579488A1 Glycosylceramide adjuvant for saccharide antigens |
| 03/16/2006 | CA2579353A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 03/16/2006 | CA2578052A1 Methods of activating nkt cells |
| 03/16/2006 | CA2577610A1 Sigma receptor ligands |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/16/2006 | CA2577405A1 Anti-fc-gamma riib receptor antibody and uses therefor |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634873A1 Sigma receptor inhibitors |
| 03/15/2006 | EP1634872A1 Pyrazole derivatives as sigma receptor inhibitors |
| 03/15/2006 | EP1634601A2 Dietary supplement comprising soyabean, mushroom and mung bean |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634599A1 Iimmune stimulatory infant nutrition |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633717A1 New p2x7 receptor antagonists and their use |
| 03/15/2006 | EP1633396A1 Cd20 binding molecules |
| 03/15/2006 | EP1633373A1 Pharmaceutical composition comprising glucan derived from microalgae |
| 03/15/2006 | EP1633363A1 Pyridinyl acetonitriles |
| 03/15/2006 | EP1633359A1 Use of efletirizine for treating persistent allergic rhinitis |
| 03/15/2006 | EP1633316A2 Antibodies that immunospecifically bind to trail receptors |
| 03/15/2006 | EP1633315A2 Novel immunomodulating peptide |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309593B1 Substituted pyrazoles |
| 03/15/2006 | EP1128842B1 Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP1035863B1 An over-expressing homologous antigen vaccine and a method of making the same |
| 03/15/2006 | EP0956859B1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0870049B1 Complementary adenoviral vector systems and cell lines |
| 03/15/2006 | EP0784477B1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 03/15/2006 | EP0733064B1 Nucleic acids encoding a house dust mite allergen, (der p iii), and uses therefor |
| 03/15/2006 | CN1747746A Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 03/15/2006 | CN1747743A Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245212C Cyclosporin A dispersion solid and its preparation method |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245200C Lindera root essence and its producing method |
| 03/15/2006 | CN1245189C Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving mental stress and promoting blood circulation to remove blood stasis |
| 03/15/2006 | CN1245164C Cell growth regulating factor oral liquid and its preparation process |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012135 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012083 For prophylaxis and therapy of pruritus |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |